Carcinoma, Neuroendocrine Clinical Trials in Bethesda, Maryland
3 recruitingBethesda, Maryland
Showing 1–3 of 3 trials
Recruiting
Phase 2
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Carcinoma, NeuroendocrineTumor, NeuroendocrineTumors, Neuroendocrine
National Cancer Institute (NCI)60 enrolled1 locationNCT06406465
Recruiting
Phase 1
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
Neuroendocrine TumorsCarcinoma, NeuroendocrineNeuroendocrine Carcinomas+2 more
National Cancer Institute (NCI)70 enrolled1 locationNCT06041516
Recruiting
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
Neuroendocrine TumorsCarcinoma, Neuroendocrine
National Cancer Institute (NCI)300 enrolled1 locationNCT05237934